TDB exerts multifaceted effects, including suppression of proliferation, induction of apoptosis, inhibition of mTOR signaling, attenuation of EMT-driven migration, and enhancement of TMZ efficacy—even in a patient-derived GBM model. The gene discussed is MTOR; the disease is glioblastoma.